INO - Inovio Pharmaceuticals, Inc.

Inovio Inks $35M Drug Deal With Chinese Biomed - https://finance.yahoo.com/m/f30e7bfa-b97e-30d4-af88-cf3e63d1b3f9/ss_inovio-inks-$35m-drug-deal.html

 

B-day stuff today so little time to do any posting but nice pop this morning and also nice little present for me. Still has FDA hold but good news >> Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study https://finance.yahoo.com/news/inovio-hiv-vaccine-elicits-nearly-120000300.html

 

Shares of Inovio Pharmaceuticals ($INO) have spiked higher in trading after the company said its HIV vaccine produced amongst the highest overall levels of immune response rates ever demonstrated in a human study.

 

forgot to post this earlier. Always keep a position here because i do believe in this company/Kim. Was hoping for a dip down to $7 or lower to pick up more for playing but not sure it's gonna happen but never can be too sure with this one either!

Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint Inhibitor https://finance.yahoo.com/news/inovio-announces-clinical-trial-collaboration-120000607.html

 

Will be very great if this becomes a reality Only posting INO blurb.

3 Stocks That Could Put Amazon's Returns to Shame
"... George Budwell (Inovio Pharmaceuticals): If you're hunting for stocks with a realistic shot at replicating Amazon's mind-boggling growth curve, you're probably gonna need to mine the depths of the speculative biotech space. As a prime example, the DNA-based vaccine maker Inovio Pharmaceuticals is a name that has some truly staggering growth potential based on its current clinical line-up -- but it also comes with a hefty dose of risk that may unnerve more conservative investors.

Inovio's value proposition hinges on the success -- or failure -- of its DNA-based vaccine platform to provide novel treatment options for patients with cancer or infectious diseases like HIV. While these next-generation vaccines offer an unusually rapid development timeline and a potentially unprecedented ability to fight emerging infectious diseases in a timely manner, they have also struggled to produce high enough efficacy levels to warrant a regulatory approval for human subjects -- at least so far.

Inovio believes its Cellectra 5PSP delivery device and the addition of immune-boosting agents can solve this lingering problem -- paving the wave for a flurry of DNA-based vaccines in the coming decades.

The first real test of the company's proposition is its late-stage candidate VGX-3100 that's initially targeting women with cervical dysplasia caused by the human papillomavirus. The main drawback with this stock is that VGX-3100 is, at a minimum, two years away from producing a top-line readout that might lead to a regulatory approval. In the meantime, the company is probably going to rely on the public markets for financing to a large degree. If Inovio strikes gold with VGX-3100 and validates its platform, though, this stock could produce some awe-inspiring gains for early investors...." https://www.fool.com/investing/2017/06/13/3-stocks-that-could-put-amazons-returns-to-shame.aspx

 

Have been meaning to post this and might wanna keep on radar - not a Zack's person but price target increased to $8.75 a few days back.

 

So much for that $8.75 pt & think i may be about done w/this company >>Inovio Announces Proposed Public Offering of Common Stock https://finance.yahoo.com/news/inovio-announces-proposed-public-offering-200100020.html

 

Not mad anymore - did my very FIRST short today and just got the following email news a few minutes ago and looks like i shoulda/coulda held overnight but may be playing with the bears again tomorrow

Inovio Announces Pricing of Public Offering of Common Stock

PLYMOUTH MEETING, Pa., July 19, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the pricing of an underwritten public offering of 12,500,000 shares of its common stock, offered at a price to the public of $6.00 per share. The gross proceeds to Inovio from the offering are expected to be $75.0 million, before deducting the underwriting discounts and commissions and offering expenses payable by Inovio. All of the shares are being offered by Inovio. The offering is expected to close on July 25, 2017, subject to customary closing conditions. In addition, Inovio has granted the underwriters a 30 day option to purchase up to 1,875,000 additional shares of its common stock on the same terms and conditions.

 

Updating with news that had running up higher than it's been in awhile but not enough to carry it back to $7-$8's. Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with Recurrent Prostate Cancer - https://finance.yahoo.com/news/inovio-cancer-immunotherapy-ino-5150-120000890.html

 

News update from this morning and surprise surprise - held $6's today BUT tomorrow is Friday lol...Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies - https://finance.yahoo.com/news/inovio-dmab-constructs-shrink-prostate-120000375.html

 

looks like INO ready to goooooooo

 

Opened around $7 before retracing & still holding what i have left for that big pay-off day if it ever comes lol -- Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers - https://realmoney.thestreet.com/art...tech-movers?puc=yahoo&cm_ven=YAHOO&yptr=yahoo

 

Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer - https://finance.yahoo.com/news/inovio-pharmaceuticals-begins-phase-1b-110000554.html

 

You are all waiting for $6 instead of just taking $6.21 - in 24 months this will be pushing $20 and you all be wishing you filled the truck now!

 

Still have core & watching for entry to start swinging this again. Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study - https://finance.yahoo.com/news/inovio-u-army-co-developing-120000279.html

 

Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhibitor - https://finance.yahoo.com/news/inovio-pharmaceuticals-initiates-immuno-oncology-131826542.html

 

Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China - https://finance.yahoo.com/news/inovio-enters-license-collaboration-agreement-130000016.html

 

still holding core but could not pass up latest lows & $5 ranges hopefully coming back soon - Inovio revamps China deal; nets $23M upfront payment https://www.bizjournals.com/philade...23m-upfront-payment.html?ana=yahoo&yptr=yahoo